What does EPS Bio Technology Corp. do?

EPS Bio Technology Corp. (4183.TWO) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4183.TWO's market cap?

EPS Bio Technology Corp. (4183.TWO) has a market capitalization of approximately $333.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 4183.TWO pay a dividend?

Yes — EPS Bio Technology Corp. (4183.TWO) pays a dividend annually, with a trailing-twelve-month yield of 4.79%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 4183.TWO profitable?

EPS Bio Technology Corp. (4183.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

4183.TWO

EPS Bio Technology Corp.

TWO·Medical, Specialties · Healthcare

NT$14.00NT$0.30+2.19%

Market capNT$333.20M·Market closed·Aug 27 5:21 AM UTC

Price Chart

NT$14.00+NT$0.30 (+2.19%)today

−24.53%CAGR −5.47%

Select date range

FromTo

Nov 13, 2012Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)4.79%

Annual Dividend (FWD)NT$0.67

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.670

Ex-Dividend DateAug 28

Payment DateSep 26

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 7

Last Report DateMar 19

Reported vs EstimateNT$0.15

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$418.74M

Net Income−NT$9.85M

Net Margin−2.4%

Operating Cash FlowNT$9.73M

Capital ExpendituresNT$18.02M

Free Cash Flow−NT$8.29M

Return on Equity−3.7%

Return on Invested Capital−0.1%

Net DebtNT$6.34M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4183.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4183.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4183.TWO and 80,000+ other tickers.

About EPS Bio Technology Corp.

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

CEO: Chen Hui Cho
Sector: Healthcare
Industry: Medical - Specialties
Exchange: TWO
Employees: 108
Website: www.epsbio.com

Peers

Peers Tab

7607.TWO

DuoGenic StemCells corporation

Taiwan Advanced Nanotech Inc.

Cap

NT$363.8M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4183.TWO

What does EPS Bio Technology Corp. do?: EPS Bio Technology Corp. (4183.TWO) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4183.TWO's market cap?: EPS Bio Technology Corp. (4183.TWO) has a market capitalization of approximately $333.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 4183.TWO pay a dividend?: Yes — EPS Bio Technology Corp. (4183.TWO) pays a dividend annually, with a trailing-twelve-month yield of 4.79%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 4183.TWO profitable?: EPS Bio Technology Corp. (4183.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.